ANG Wee Han

ANG Wee Han is a Professor in the Department of Chemistry at the National University of Singapore (NUS), serving dual roles as Vice Dean (Special Duties) and Associate Provost overseeing NUS's Multidisciplinary and Interdisciplinary Masters’ Programmes. His research focuses on developing therapeutic metallopharmaceuticals, particularly transition metal-based drugs for cancer and antibacterial therapies. He holds a PhD from the École Polytechnique Fédérale de Lausanne (2007) and a Postdoc from MIT (2009), complemented by a BSc from Imperial College London (1995).

Research interests include platinum(IV) prodrugs, ruthenium-based anticancer complexes, and immunogenic cell death mechanisms. Notable achievements include the EPFL Doctorate Prize (2008) and leadership roles in conferences like AsBIC-9. His lab, the Laboratory of Bioinorganic Chemistry, explores drug design, fluorescent probes, and combinatorial chemistry, with over 150 publications in high-impact journals. Collaborations span drug discovery, nanomedicine, and clinical applications such as oxaliplatin-based chemotherapy.

ANG has mentored numerous students, including Zhi Chiaw (PhD thesis on cellular ROS responses), Violet Lee Eng Yee (platinum prodrug research), and Kwan Wei (CO2 removal studies). His work bridges chemistry and medicine, addressing challenges in drug resistance, targeted delivery, and immune modulation.